BioCentury | Jul 27, 2018
Company News

I-Mab, ABL partner in antibody deals

...rights worldwide. In June, I-Mab raised $220 million in a series C round led by Hony Capital...
BioCentury | Jul 13, 2018
Financial News

I-Mab raises $220M in series C

...Biopharma (Shanghai, China) raised $220 million June 29 in a series C round led by Hony Capital...
BioCentury | Jun 29, 2018
Financial News

I-Mab continues trend of large Chinese-led venture rounds

...I-Mab Biopharma (Shanghai, China) raised $220 million Friday in a series C round led by Hony Capital...
Items per page:
1 - 3 of 3
BioCentury | Jul 27, 2018
Company News

I-Mab, ABL partner in antibody deals

...rights worldwide. In June, I-Mab raised $220 million in a series C round led by Hony Capital...
BioCentury | Jul 13, 2018
Financial News

I-Mab raises $220M in series C

...Biopharma (Shanghai, China) raised $220 million June 29 in a series C round led by Hony Capital...
BioCentury | Jun 29, 2018
Financial News

I-Mab continues trend of large Chinese-led venture rounds

...I-Mab Biopharma (Shanghai, China) raised $220 million Friday in a series C round led by Hony Capital...
Items per page:
1 - 3 of 3